| ID |
date |
title |
| 1226 |
1/4/2010 |
Pedunculopontine Stimulation Effect on PD Gait Variable, Modest
|
| 1228 |
1/11/2010 |
Amyloid Pathology in PD Doesn’t Necessarily Mean Alzheimer’s Dementia
|
| 1229 |
1/15/2010 |
LRRK2 Accelerates alpha-Synuclein Aggregation and Neurodegeneration
|
| 1230 |
1/19/2010 |
The “Clinically Important Difference” in UPDRS Score
|
| 1232 |
1/25/2010 |
Severity of REM Atonia Loss in RBD Predicts PD
|
| 1234 |
1/28/2010 |
Extrasynaptic Glutamate Signaling May Be An Early Event in HD Pathogenesis
|
| 1235 |
2/8/2010 |
Anosmia and Autonomic Failure are Associated in PD
|
| 1236 |
2/10/2010 |
Latrepirdine for Cognition in Huntington’s Disease
|
| 1237 |
2/12/2010 |
Is Essential Tremor a Neurodegenerative Disease?
|
| 1238 |
2/15/2010 |
Nation-wide PD Epidemiologic Study Finds Geographic, Ethnic Differences
|
| 1239 |
2/17/2010 |
Vitamin B6 Gene Implicated in PD
|
| 1240 |
2/19/2010 |
Minocycline Ineffective in MSA
|
| 1241 |
2/24/2010 |
Dopamine Agonist Withdrawal Syndrome in PD Patients with Impulse Control Disorder
|
| 1243 |
2/26/2010 |
Benefit from Dopamine Pathway Gene Therapy in Advanced PD Model
|
| 1244 |
3/8/2010 |
IGF-1 May be a Biomarker for Early Parkinson’s Disease
|
| 1245 |
3/10/2010 |
FDA Approves Botox for Spasticity Treatment
|
| 1247 |
3/18/2010 |
Calcium Channel Blockers May Reduce the Risk of Parkinson’s Disease
|
| 1248 |
3/19/2010 |
Riluzole for Cerebellar Ataxia
|
| 1249 |
3/25/2010 |
Duration of Smoking, not Intensity, Reduces PD Risk
|
| 1250 |
3/26/2010 |
AAN Practice Parameter on Treatment of Non-motor PD Symptoms
|
| 1251 |
3/31/2010 |
High Rate of Melanoma in PD Patients
|
| 1252 |
4/10/2010 |
Bicycling in PD Despite Freezing of Gait
|
| 1253 |
4/19/2010 |
Caffeine Lowers Age of Onset in Huntington's Disease (AAN 2010)
|
| 1254 |
4/22/2010 |
Gene Screen in Early PD Highlights Parkin, GBA, and LRRK2 (AAN 2010)
|
| 1255 |
4/27/2010 |
Antibody Experience with Long-Term Use of MyoBloc (AAN 2010)
|
| 1256 |
4/28/2010 |
Ten-Year Follow-up of Hallucinations in PD (AAN 2010)
|
| 1258 |
5/4/2010 |
Diagnosis, Prescribing, and Comorbidity Patterns in Early PD (AAN 2010)
|
| 1259 |
5/6/2010 |
New Tourette Syndrome Gene Implicates Histamine Signaling
|
| 1260 |
5/11/2010 |
FDA Rejects Refrigeration for Neupro, Requires Reformulation
|
| 1261 |
5/13/2010 |
Gabapentin Enacarbil for RLS (AAN 2010)
|
| 1263 |
5/21/2010 |
Ibuprofen Reduces PD Risk (AAN 2010)
|
| 1264 |
5/24/2010 |
New Extended-Release Levodopa Reduces Off Time versus IR Levodopa (AAN 2010)
|
| 1265 |
5/31/2010 |
RLS More Common in Migraine than in Other Headache Types
|
| 1266 |
6/8/2010 |
Late-state PD Progression Independent of Patient Age
|
| 1267 |
6/14/2010 |
Compound Stains Alpha-synuclein In Vivo
|
| 1268 |
6/21/2010 |
Gene-Pesticide Interaction Increases PD Risk
|
| 1269 |
6/29/2010 |
Peripheral Neuropathy in PD
|
| 1271 |
7/26/2010 |
High Vitamin D Associated with Reduced PD Risk
|
| 1274 |
8/10/2010 |
FDA Approves Xeomin (IncobotulinumtoxinA)
|
| 1276 |
8/19/2010 |
PD Risk Linked to HLA Gene
|
| 1277 |
8/26/2010 |
Placebo-induced Dopamine Release in PD Patients Varies with Expectation of Active Medication
|
| 1278 |
9/8/2010 |
Amantadine for Pathological Gambling in PD
|
| 1282 |
11/4/2010 |
DYT6 Protein Interacts with DYT1 Gene
|
| 1283 |
11/11/2010 |
Dopamine Agonist Reduces Inhibitory Brain Activity in PD Gamblers
|
| 1284 |
11/17/2010 |
New Pediatric Movement Disorders CME Activity from WE MOVE
|
| 1285 |
11/24/2010 |
In Some PD Cases, Pathogenesis “May Span Most of the Lifetime”
|
| 1286 |
11/29/2010 |
AAN Announces 10 Quality Measures for PD Care
|
